Here's their timeline from the last AGM in November (with some annotations I made at the time). Outrageously ridiculous which many of us knew at the time.
Also, I know the company sometimes referred to these phase 1 trials as sepsis trials, but we need to keep in mind that they are simply IV formulation trials. Sepsis is off the table for now I believe due to poor plasma concentrations. UTI our best bet for this formulation, but we'll need to see how actual patients respond in the coming phase 2.
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete, page-66
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
0.005(0.97%) |
Mkt cap ! $120.5M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 54.0¢ | 52.0¢ | $4.485K | 8.497K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 14897 | 2 |
View Market Depth
| Last trade - 15.47pm 04/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |